Clinical Trial Update: Ketamine Associated ACC GABA and Glutamate Change and Depression Remission: [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial reports ketamine-associated changes in ACC GABA and glutamate and notes depression remission. The study targets major depressive disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Mayo Clinic | Conditions: Major Depressive Disorder, Treatment Resistant Depression | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING